NDC 66582-312

VYTORIN

Ezetimibe And Simvastatin

VYTORIN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Ezetimibe; Simvastatin.

Product ID66582-312_5054bba3-abe5-4162-b9ae-13dafb65d313
NDC66582-312
Product TypeHuman Prescription Drug
Proprietary NameVYTORIN
Generic NameEzetimibe And Simvastatin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2004-07-23
Marketing CategoryNDA / NDA
Application NumberNDA021687
Labeler NameMerck Sharp & Dohme Corp.
Substance NameEZETIMIBE; SIMVASTATIN
Active Ingredient Strength10 mg/1; mg/1
Pharm ClassesDecreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 66582-312-31

30 TABLET in 1 BOTTLE (66582-312-31)
Marketing Start Date2004-07-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66582-312-27 [66582031227]

VYTORIN TABLET
Marketing CategoryNDA
Application NumberNDA021687
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-07-23
Marketing End Date2017-08-31

NDC 66582-312-28 [66582031228]

VYTORIN TABLET
Marketing CategoryNDA
Application NumberNDA021687
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-07-23
Marketing End Date2012-05-08

NDC 66582-312-87 [66582031287]

VYTORIN TABLET
Marketing CategoryNDA
Application NumberNDA021687
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-07-23
Marketing End Date2018-11-30

NDC 66582-312-01 [66582031201]

VYTORIN TABLET
Marketing CategoryNDA
Application NumberNDA021687
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2004-07-23

NDC 66582-312-82 [66582031282]

VYTORIN TABLET
Marketing CategoryNDA
Application NumberNDA021687
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-07-23
Marketing End Date2018-08-31

NDC 66582-312-31 [66582031231]

VYTORIN TABLET
Marketing CategoryNDA
Application NumberNDA021687
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-07-23

NDC 66582-312-54 [66582031254]

VYTORIN TABLET
Marketing CategoryNDA
Application NumberNDA021687
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-07-23

Drug Details

Pharmacological Class

  • Decreased Cholesterol Absorption [PE]
  • Dietary Cholesterol Absorption Inhibitor [EPC]
  • HMG-CoA Reductase Inhibitor [EPC]
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Medicade Reported Pricing

66582031287 VYTORIN 10-20 MG TABLET

Pricing Unit: EA | Drug Type:

66582031282 VYTORIN 10-20 MG TABLET

Pricing Unit: EA | Drug Type:

66582031254 VYTORIN 10-20 MG TABLET

Pricing Unit: EA | Drug Type:

66582031231 VYTORIN 10-20 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "VYTORIN" or generic name "Ezetimibe And Simvastatin"

NDCBrand NameGeneric Name
21695-325VYTORINezetimibe and simvastatin
21695-339VYTORINezetimibe and simvastatin
21695-827VYTORINezetimibe and simvastatin
55289-520VYTORINVYTORIN
55289-280VYTORINVYTORIN
66582-311VYTORINVYTORIN
66582-313VYTORINVYTORIN
66582-315VYTORINVYTORIN
66582-312VYTORINVYTORIN
0115-1385Ezetimibe and SimvastatinEZETIMIBE and SIMVASTATIN
0115-1386Ezetimibe and SimvastatinEZETIMIBE and SIMVASTATIN
0115-1387Ezetimibe and SimvastatinEZETIMIBE and SIMVASTATIN
0115-1388Ezetimibe and SimvastatinEZETIMIBE and SIMVASTATIN
16714-778ezetimibe and simvastatinezetimibe and simvastatin
16714-779ezetimibe and simvastatinezetimibe and simvastatin
16714-780ezetimibe and simvastatinezetimibe and simvastatin
16714-781ezetimibe and simvastatinezetimibe and simvastatin
42291-078Ezetimibe and SimvastatinEzetimibe and Simvastatin
42291-079Ezetimibe and SimvastatinEzetimibe and Simvastatin
42291-080Ezetimibe and SimvastatinEzetimibe and Simvastatin
42291-081Ezetimibe and SimvastatinEzetimibe and Simvastatin
43598-583Ezetimibe and SimvastatinEzetimibe and Simvastatin
43598-584Ezetimibe and SimvastatinEzetimibe and Simvastatin
43598-585Ezetimibe and SimvastatinEzetimibe and Simvastatin
43598-586Ezetimibe and SimvastatinEzetimibe and Simvastatin
43598-742Ezetimibe and SimvastatinEzetimibe and Simvastatin
43598-743Ezetimibe and SimvastatinEzetimibe and Simvastatin
43598-744Ezetimibe and SimvastatinEzetimibe and Simvastatin
43598-745Ezetimibe and SimvastatinEzetimibe and Simvastatin
45963-565Ezetimibe and SimvastatinEzetimibe and Simvastatin

Trademark Results [VYTORIN]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VYTORIN
VYTORIN
76492611 2946492 Live/Registered
MSD INTERNATIONAL GMBH
2003-02-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.